% Expired Patents = 50.0

EPO Patents = 1

Trademarks = 1

Forward Citations = 10

Loading Chart...

4 inventors (with patents filed for the assignee):

Mark Tepper (6 out of 14 patents)

Dean A Frey (4 out of 4 patents)

David Goeddel (4 out of 4 patents)

4. Karl Reineke (4 out of 9 patents)

5. Robert B Zurier (4 patents)

6. Enrico Selvi (0 patent)

6 patents: Sort by Forward Citations

1. 11052066 - Ultrapure tetrahydrocannabinol-11-oic acids (2021-07-06),

2. 10369131 - Ultrapure tetrahydrocannabinol-11-oic acids (2019-08-06),

3. 10154986 - Ultrapure tetrahydrocannabinol-11-oic acids (2018-12-18),

4. 10085964 - Ultrapure tetrahydrocannabinol-11-oic acids (2018-10-02),

5. 9820964 - Ultrapure tetrahydrocannabinol-11-oic acids (2017-11-21),

6. 9801849 - Ultrapure tetrahydrocannabinol-11-oic acids (2017-10-31),

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The company's lead product candidate, lenabasum, is a synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Corbus is committed to improving the lives of patients through innovative treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

6 Patents

#22 in Norwood, MA

#2,537 in Massachusetts

#44,887 in US

Norwood, MA, United States of America

Corbus Pharmaceuticals, Inc.